Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1689126

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1689126

North America Glucose Monitoring Market Outlook to 2033 - Blood Glucose Meters

PUBLISHED:
PAGES: 85 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

GlobalData's "North America Glucose Monitoring Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Blood Glucose Meters

The North America Glucose Monitoring Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Glucose Monitoring Market.
  • Global corporate-level profiles of key companies operating within the North America Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Glucose Monitoring is segmented as follows -

  • Blood Glucose Meters

Reasons to Buy

The North America Glucose Monitoring Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME20127CRDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Glucose Monitoring Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Glucose Monitoring Market, North America

  • 3.1 Glucose Monitoring Market, North America, Revenue ($m), 2018-2033
  • 3.2 Glucose Monitoring Market, North America, Revenue ($m), 2018-2033
  • 3.3 Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • 3.4 Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • 3.5 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2023

4 Glucose Monitoring Market, Canada

  • 4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2018-2033
    • 4.1.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2018-2033
  • 4.2 Glucose Monitoring Market, Canada, Volume (Units), 2018-2033
    • 4.2.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2018-2033
  • 4.3 Glucose Monitoring Market, Canada, Average Price ($) , 2018-2033
  • 4.4 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2023
  • 4.5 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2023

5 Glucose Monitoring Market, United States

  • 5.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033
    • 5.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2018-2033
  • 5.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033
    • 5.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2018-2033
  • 5.3 Glucose Monitoring Market, United States, Average Price ($) , 2018-2033
  • 5.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2023
  • 5.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2023

6 Glucose Monitoring Market, Mexico

  • 6.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2018-2033
    • 6.1.1 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2018-2033
  • 6.2 Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033
    • 6.2.1 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2018-2033
  • 6.3 Glucose Monitoring Market, Mexico, Average Price ($) , 2018-2033
  • 6.4 Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), 2023
  • 6.5 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2023

7 Overview of Key Companies in North America Glucose Monitoring Market

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
  • 7.2 DexCom Inc
    • 7.2.1 Company Overview
  • 7.3 Medtronic Plc
    • 7.3.1 Company Overview

8 Glucose Monitoring Market Pipeline Products

9 Recent Developments

  • 9.1 Corporate Communications
    • 9.1.1 Jan 21, 2025: Glucotrack Announces ISO 13485:2016 Certification
    • 9.1.2 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
    • 9.1.3 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
    • 9.1.4 Jul 05, 2024: Afamelanotide Assists DNA Repair Response Following UV Radiation
    • 9.1.5 Jun 03, 2024: Kimball Electronics Appoints New Treasurer
  • 9.2 Financial Announcements
    • 9.2.1 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results
    • 9.2.2 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
    • 9.2.3 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024
    • 9.2.4 Jul 25, 2024: Senseonics Holdings Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
    • 9.2.5 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
    • 9.2.6 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024
    • 9.2.7 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
    • 9.2.8 May 07, 2024: Kimball Electronics Reports Q3 Results; Company Announces Renewed Strategic Focus, Including Expected Divestiture of the Automation, Test & Measurement Business
    • 9.2.9 Apr 04, 2024: BD to Announce Financial Results for its Second Quarter of Fiscal 2024
  • 9.3 Government and Public Interest
    • 9.3.1 Jan 07, 2025: New Publication Highlights Safety and Potential Benefits of Redosing Diamyd Precision Medicine for Type 1 Diabetes
    • 9.3.2 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo
    • 9.3.3 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
    • 9.3.4 Jun 03, 2024: Kimball Electronics Appoints New Treasurer
    • 9.3.5 Jun 01, 2024: Typhoid Fever Vaccine "Tyfim V-I Injection Syringe" Information Regarding Obtaining Manufacturing and Sales Approval
    • 9.3.6 May 27, 2024: Qurient Unveils Q901 ASCO Abstract... Verification of safety and drug response
    • 9.3.7 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
    • 9.3.8 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024
    • 9.3.9 Apr 24, 2024: Merus Announces Presentation MCLA-129 at the 2024 ASCO Annual Meeting
    • 9.3.10 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC)
    • 9.3.11 Apr 04, 2024: Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
    • 9.3.12 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference
    • 9.3.13 Feb 15, 2024: BD to Present at Investor Healthcare Conferences
    • 9.3.14 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
  • 9.4 Legal And Regulatory
    • 9.4.1 Nov 12, 2024: ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV
    • 9.4.2 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
  • 9.5 Other Significant Developments
    • 9.5.1 Dec 20, 2024: Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
    • 9.5.2 Jun 06, 2024: LIFE Sterilization protocol ready for the production line
    • 9.5.3 Feb 12, 2024: Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System
  • 9.6 Product News
    • 9.6.1 Jan 06, 2025: Introducing isaac by PreEvnt - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit
    • 9.6.2 Oct 02, 2024: Rice's Biotech Launch Pad to Lead Commercialization of Bioelectrical Implant Treatment for Obesity, Type 2 Diabetes
  • 9.7 Strategy And Business Planning
    • 9.7.1 Oct 01, 2024: Glytec and Ardent Partner to Boost Diabetes and Insulin Management Nationwide
    • 9.7.2 May 14, 2024: Glytec and University Hospitals (UH) Forge Strategic Partnership
    • 9.7.3 Apr 18, 2024: Glytec Announces Support for Landmark New CMS Measures to Improve Diabetes Reporting

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Coverage
    • 10.1.2 Secondary Research
    • 10.1.3 Primary Research
    • 10.1.4 Market Modeling and Forecasting
    • 10.1.5 Company Share Analysis
    • 10.1.6 Distribution Share Analysis
    • 10.1.7 Benchmarking
  • 10.2 GlobalData Consulting
  • 10.3 Contact Us
  • 10.4 Disclaimer
Product Code: GDME20127CRDB

List of Table

List of Tables

  • Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Glucose Monitoring Market, North America, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • Table 4: Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • Table 5: Glucose Monitoring Market, North America, Company Share by Revenue ($m), USD Constant, 2023
  • Table 6: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 7: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 8: Glucose Monitoring Market, Canada, Volume (Units), 2018-2033
  • Table 9: Blood Glucose Meters Market, Canada, Volume (Units), 2018-2033
  • Table 10: Glucose Monitoring Market, Canada, Average Price ($), 2018-2033
  • Table 11: Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 12: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
  • Table 13: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 14: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 15: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
  • Table 16: Blood Glucose Meters Market, United States, Volume (Units), 2018-2033
  • Table 17: Glucose Monitoring Market, United States, Average Price ($), 2018-2033
  • Table 18: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 19: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2023
  • Table 20: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 21: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 22: Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033
  • Table 23: Blood Glucose Meters Market, Mexico, Volume (Units), 2018-2033
  • Table 24: Glucose Monitoring Market, Mexico, Average Price ($), 2018-2033
  • Table 25: Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 26: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), USD Constant, 2023
  • Table 27: Glucose Monitoring Market Pipeline Products

List of Figure

List of Figures

  • Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Glucose Monitoring Market, North America, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • Figure 4: Glucose Monitoring Market, North America, Volume (Units), 2018-2033
  • Figure 5: Glucose Monitoring Market, North America, Company Share (%) 2023
  • Figure 6: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: Glucose Monitoring Market, Canada, Volume (Units), 2018-2033
  • Figure 9: Blood Glucose Meters Market, Canada, Volume (Units), 2018-2033
  • Figure 10: Glucose Monitoring Market, Canada, Company Share (%) 2023
  • Figure 11: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 13: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
  • Figure 14: Blood Glucose Meters Market, United States, Volume (Units), 2018-2033
  • Figure 15: Glucose Monitoring Market, United States, Company Share (%) 2023
  • Figure 16: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 17: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 18: Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033
  • Figure 19: Blood Glucose Meters Market, Mexico, Volume (Units), 2018-2033
  • Figure 20: Glucose Monitoring Market, Mexico, Company Share (%) 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!